Increased activity of the α1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome

International Journal of Biochemistry and Cell Biology

Volumn 29, Issue 1, 1997, Pages 135-141

  Hitraya, Elena G ^a   Jimenez, Sergio A ^a   Ludwicka, Anna ^b   Silver, Richard M ^b   Varga, John ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Eosinophilia myalgia syndrome (EMS); Fibrosis collagen; Skin fibroblasts

Indexed keywords

ALPHA1 PROCOLLAGEN; COLLAGEN TYPE 1; PROCOLLAGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DELETION MUTANT; EOSINOPHILIA MYALGIA SYNDROME; FEMALE; FIBROSIS; GENE CONSTRUCT; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; SKIN FIBROBLAST;

ADULT; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DRUG CONTAMINATION; EOSINOPHILIA-MYALGIA SYNDROME; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENES, REPORTER; HUMANS; MIDDLE AGED; PROCOLLAGEN; PROMOTER REGIONS (GENETICS); SKIN; TRANSFECTION; TRYPTOPHAN;

TRIXIS;

EID: 0031034103     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(96)00125-2     Document Type: Article

References (33)

1. Abken H. and Reifenrath B. (1992) A procedure to standardize CAT reporter gene assay. Nucl. Acids Res. 29, 3527-3528.
2. Belongia E. A., Hedberg C. W. and Gleich G. J. et al. (1990) An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N. Engl. J. Med. 323, 357-365.
3. Blauvelt A. and Falanga V. (1991) Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination. Arch. Dermatol. 127, 1159-1166.
4. Border W. A. and Noble N. A. (1994) Transforming growth factor-β in tissue fibrosis. N. Engl. J. Med. 331, 1286-1292.
5. Clements P., Lachenbruch P. and Siebold J. et al. (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J. Rheumatol. 22, 1281-1285.
6. Cox D., Earle E., Lieferman K., Jimenez S. A., Gleich G. J. and Varga J. (1995) Elevated levels of eosinophil major basic protein in the sera of patients with systemic sclerosis. Arthritis Rheum. 38, 939-945.
7. Eosinophilia-myalgia syndrome - New Mexico (1989) J. Am. Med. Assoc. 262, 3116.
8. Feldman S. R., Silver R. M. and Maize J. C. (1992) A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome. J. Am. Acad. Dermatol. 26, 95-100.
9. Graham F. and Van der Ab A. J. (1973) A new technique for the assay of infectivity of the human adenovirus 5 DNA. Virology 54, 536-539.
10. Hertzman P. A., Blevins W. L. and Mayer J. et al. (1990) Association of the eosinophilia-myalgia syndrome with the ingestion of L-tryptophan. N. Engl. J. Med. 332, 869-873.
11. Hertzman P. A., Clauw D. J. and Kaufman L. D. et al. (1995) The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Ann. Intern. Med. 122, 851-855.
12. Jimenez S. A., Varga J. and Olsen A. et al. (1994) Functional analysis of human α1 (I) procollagen gene promoter. J. biol. Chem. 269, 12684-12691.
13. Kaufman L. D., Gruber B. L., Gomez-Reino J. J. and Miller F. (1994) Fibrogenic growth factors in the eosinophilia-myalgia syndrome and the toxic oil syndrome. Arch. Dermatol. 130,w 41-47.
14. Li L., Artlett C., Jimenez S. A., Hall D. J. and Varga J. (1995) Stimulation of type I collagen transcription by transforming growth factor-β in human fibroblasts: demonstration of the involvement of an Sp1-like protein. Gene 164, 229-234.
15. Lin J. D., Phelps R. G. and Gordon M. L. et al. (1992) Pathologic manifestations of the eosinophilia-myalgia syndrome: analysis of 11 cases. Hum. Pathol. 23, 429-437.
16. Ludwicka A., Hampton M., Bolster M. et al. A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia-myalgis syndrome. Proc. Assoc. Am. Physicians, in press.
17. Martin R. W., Duffy J. and Engel A. G. et al. (1990) The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann. Intern. Med. 113, 124-134.
18. Noguchi H., Kephart G. M., Colby T. V. and Gleich G. J. (1992) Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am. J. Pathol. 140, 521-528.
19. Ohno I., Lea R. G. and Flanders K. C. et al. (1992) Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor-β1 gene (TGF-β1). J. Clin. Invest. 89, 1662-1668.
20. Peltonen J., Varga J. and Sollberg S. et al. (1991) Elevated expression of the genes for transforming growth factor-β and type VI collagen in diffuse faciitis associated with the eosinophilia-myalgia syndrome. J. Invest. Derm. 96, 20-25.
21. Raghow R. (1994) The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J. 8, 823-831.
22. Roberts A. B., McCune B. K. and Sporn M. B. (1992) TGF-β: regulation of extracellular matrix. Kidney Int. 41, 557-559.
23. Sambrook J., Fritsch E. and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
24. Silver R. M., Heyes M. P. and Maize J. C. et al. (1990) Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan. N. Engl. J. Med. 322, 874-881.
25. Silver R. M., Ludwicka A. and Hampton M. et al. (1994) A murine model of the eosinophilia-myalgia syndrome induced by 1,1′-ethylidenebis (L-tryptophan). J. Clin. Invest. 93, 1473-1480.
26. Uitto J. and Jimenez S. A. (1990) Fibrotic skin diseases. Arch Dermatol. 126, 661-663.
27. Umbert I., Winkelmann R. K. and Wegener L. (1993) Comparison of the pathology of fascia in eosinophilic myalgia syndrome patients and idiopathic eosinophilic fasciitis. Dermatology 186, 18-22.
28. Varga J. and Jimenez S. A. (1995) Pathogenesis of scleroderma: cellular aspects. In Systemic Sclerosis (Eds Clements P. J. and Furst D. E.), pp. 123-153. Williams and Wilkins, Philadelphia.
29. Varga J., Peltonen J. and Uitto J. M. et al. (1990) Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients. Ann. Intern. Med. 112, 344-351.
30. Varga J., Uitto J. and Jimenez S. A. (1992) The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann. Intern. Med. 116, 140-147.
31. Varga J., Li L. and Jimenez S. A. (1993) Increased type I collagen gene expression in L-tryptophan associated eosinophilia-myalgia syndrome skin fibroblasts. J. Rheumatol. 20, 1303-1308.
32. Varga J., Li L., Mauviel A., Jeffrey J. and Jimenez S. A. (1994) L-Tryptophan in supraphysiologic concentrations stimulates collagenase gene expression in human skin fibroblasts. Lab. Invest. 70, 183-192.
33. 1 by eosinophils during cutaneous wound healing in the hamster. Am. J. Pathol. 143, 130-142.